Annual Total Liabilities
$35.18 M
+$1.86 M+5.57%
December 31, 2023
Summary
- As of February 7, 2025, CRBP annual total liabilities is $35.18 million, with the most recent change of +$1.86 million (+5.57%) on December 31, 2023.
- During the last 3 years, CRBP annual total liabilities has fallen by -$21.84 million (-38.31%).
- CRBP annual total liabilities is now -38.31% below its all-time high of $57.02 million, reached on December 31, 2020.
Performance
CRBP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$13.67 M
-$12.76 M-48.28%
September 30, 2024
Summary
- As of February 7, 2025, CRBP quarterly total liabilities is $13.67 million, with the most recent change of -$12.76 million (-48.28%) on September 30, 2024.
- Over the past year, CRBP quarterly total liabilities has dropped by -$21.50 million (-61.13%).
- CRBP quarterly total liabilities is now -79.47% below its all-time high of $66.61 million, reached on September 30, 2020.
Performance
CRBP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CRBP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.6% | -61.1% |
| 3 y3 years | -38.3% | -59.0% |
| 5 y5 years | +80.7% | -59.0% |
CRBP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +5.6% | -64.6% | at low |
| 5 y | 5-year | -38.3% | +5.6% | -79.5% | at low |
| alltime | all time | -38.3% | +4666.5% | -79.5% | +2364.5% |
Corbus Pharmaceuticals Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.67 M(-48.3%) |
| Jun 2024 | - | $26.44 M(-8.1%) |
| Mar 2024 | - | $28.78 M(-18.2%) |
| Dec 2023 | $35.18 M(+5.6%) | $35.18 M(-2.2%) |
| Sep 2023 | - | $35.97 M(+5.2%) |
| Jun 2023 | - | $34.20 M(-2.8%) |
| Mar 2023 | - | $35.19 M(+5.6%) |
| Dec 2022 | $33.32 M(-13.7%) | $33.32 M(+4.5%) |
| Sep 2022 | - | $31.88 M(-2.2%) |
| Jun 2022 | - | $32.60 M(-5.6%) |
| Mar 2022 | - | $34.52 M(-10.6%) |
| Dec 2021 | $38.62 M(-32.3%) | $38.62 M(-7.9%) |
| Sep 2021 | - | $41.95 M(-3.9%) |
| Jun 2021 | - | $43.65 M(-10.2%) |
| Mar 2021 | - | $48.63 M(-14.7%) |
| Dec 2020 | $57.02 M(+32.7%) | $57.02 M(-14.4%) |
| Sep 2020 | - | $66.61 M(+34.0%) |
| Jun 2020 | - | $49.70 M(+16.9%) |
| Mar 2020 | - | $42.51 M(-1.1%) |
| Dec 2019 | $42.98 M | $42.98 M(+11.7%) |
| Sep 2019 | - | $38.49 M(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $36.75 M(-37.8%) |
| Mar 2019 | - | $59.09 M(+203.6%) |
| Dec 2018 | $19.47 M(+111.7%) | $19.47 M(+6.3%) |
| Sep 2018 | - | $18.31 M(+23.7%) |
| Jun 2018 | - | $14.80 M(+27.6%) |
| Mar 2018 | - | $11.60 M(+26.2%) |
| Dec 2017 | $9.19 M(+2.5%) | $9.19 M(+42.8%) |
| Sep 2017 | - | $6.44 M(-7.7%) |
| Jun 2017 | - | $6.97 M(-0.7%) |
| Mar 2017 | - | $7.02 M(-21.7%) |
| Dec 2016 | $8.97 M(+130.5%) | $8.97 M(+39.2%) |
| Sep 2016 | - | $6.44 M(+29.5%) |
| Jun 2016 | - | $4.97 M(+21.6%) |
| Mar 2016 | - | $4.09 M(+5.2%) |
| Dec 2015 | $3.89 M(+427.1%) | $3.89 M(+80.1%) |
| Sep 2015 | - | $2.16 M(-22.7%) |
| Jun 2015 | - | $2.80 M(+403.9%) |
| Mar 2015 | - | $554.80 K(-24.8%) |
| Dec 2014 | $738.00 K(-64.7%) | $738.00 K(+20.3%) |
| Sep 2014 | - | $613.70 K(-70.6%) |
| Dec 2013 | $2.09 M | $2.09 M |
FAQ
- What is Corbus Pharmaceuticals Holdings annual total liabilities?
- What is the all time high annual total liabilities for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual total liabilities year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly total liabilities year-on-year change?
What is Corbus Pharmaceuticals Holdings annual total liabilities?
The current annual total liabilities of CRBP is $35.18 M
What is the all time high annual total liabilities for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual total liabilities is $57.02 M
What is Corbus Pharmaceuticals Holdings annual total liabilities year-on-year change?
Over the past year, CRBP annual total liabilities has changed by +$1.86 M (+5.57%)
What is Corbus Pharmaceuticals Holdings quarterly total liabilities?
The current quarterly total liabilities of CRBP is $13.67 M
What is the all time high quarterly total liabilities for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly total liabilities is $66.61 M
What is Corbus Pharmaceuticals Holdings quarterly total liabilities year-on-year change?
Over the past year, CRBP quarterly total liabilities has changed by -$21.50 M (-61.13%)